Molecular basis of RH blood groups and Rh(null) deficiency syndrome;Bases moleculaires du systeme RH et syndrome Rh(null)

Hematologie

Volumn 3, Issue 3, 1997, Pages 207-220

  Cartron, Jean Pierre ^a   Colin, Yves ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

Blood groups; D epitope mapping; Null phenotypes; Red cell membrane; Rh antigens

Indexed keywords

AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; BLOOD GROUP RHESUS SYSTEM; CONFORMATIONAL TRANSITION; GENE MUTATION; HUMAN; PATHOGENESIS; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; REVIEW; RHESUS INCOMPATIBILITY;

EID: 0030840089     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Levine P, Katzin EM, Burnham L. Isoimmunization in pregnancy, its possible bearing on the etiology of erythroblastosis fetalis J Am Med Assoc 1941 ; 116 : 825-7.
2. Levine P, Burnham L, Katzin EM, Vogel P. The role of iso-immunization in the pathogenesis of erythroblastosis fetalis. Am J Obstetr Gynecol 1941 ; 42 : 925-7.
3. Rosse W. Autoimmune disease due to warm-reacting antibodies : immune hemolytic anemia. In : Clinical Immunohematology : basic concepts and clinical applications. Boston : Blackwell Scientific, 1990: 519-32.
4. Sturgeon P. Hematological observations on the anemia associated with blood type Rh-null. Blood 1970 ; 36 : 310-20.
5. Nash R, Shojania AM. Hematological aspect of Rh deficiency syndrome : a case report and review of the literature. Am J Hematol 1987 ; 24 : 267-75.
6. Daniels G. Human blood groups. Oxford : Blackwell Science Ltd, 1995 : 257-355.
7. Cartron JP, Agre P. Rh blood group antigens : protein and gene structure. Seminars Hematol 1993 ; 30 : 193-208.
8. Anstee DJ, Tanner MJA. Biochemical aspects of the blood group Rh (Rhesus) antigens. Baillière's Clinical Haematology 1993 ; 6 : 401-22.
9. Cartron JP. Defining the Rh blood group antigens Blood Reviews 1994 ; 8 : 199-212.
10. Lauf PK, Joiner CH. Increased potassium transport and ouabain binding in human Rh-null red blood cells. Blood 1976 ; 48 : 457-68.
11. Ballas S, Clark MR, Mohandas N, Colfe HF, Caswell MS, Bergen MO, Perkins HA, Shohet SB. Red cell membranes and cation deficiency in Rh-null syndrome. Blood 1984 ; 63 : 1046-55.
12. Kuypers F, van Linde-Sibenius-Trip M, Roelofsen B, Tanner MJA, Anstee DJ, Op den Kamp JAF. Rh-null human erythrocytes have an abnormal membrane phospholipid organization. Biochem J 1984 ; 221 : 931-4.
13. Palek J, Jarolim P. Clinical expression and laboratory detection of red blood cell membrane protein mutations. Seminars Hematol 1993 ; 30 : 249-83.
14. Delaunoy J, Alloisio N, Morlé L, Carré G. La sphérocytose héréditaire en 1995 : l'apport de la génétique moléculaire. Hématologie 1995 ; 2 : 115-22.
15. Szymanski O, Araszkiewicz P, Odgren P, Snyder LM. Decreased amount of the Rh antigen D in hereditary sperocytosis (HS). Br J Haematol 1989 ; 73 : 537-40.
16. Bailly P, Cartron JP, Wang D, Johnson RM. Hereditary stomatocytosis ana Rh-deficient patients exhibit distinct molecular defects. Blood 1992 ; 50 : 1624-6.
17. Agre P, Cartron JP. Molecular biology of Rh antigens. Blood 1991 ; 78 : 551-63.
18. Colin Y, Chérif-Zahar B, Le Van Kim C, Raynal V, Van Huffel V, Cartron JP. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism. Blood 1991 ; 78 2747-52.
19. Chérif-Zahar B, Le Van Kim C, Rouillac C, Raynal V, Cartron JP, Colin Y. Organization of the gene encoding the human blood group RhCcEe antigens and characterization of the promotor region. Genomics 1994 ; 19 : 68-74
20. Mouro I, Colin Y, Chérif-Zahar B, Cartron JP, Le Van Kim C. Molecular genetic basis of the human Rhesus blood group system. Nature Genet 1993 ; 5 : 62-5
21. Salvignol I, Calvas P, Socha WW, Colin Y, Le Van Kim C, Cartron JP, Clayton J, Ruffié J, Bloncher A. Structural analysis of the RH-like blood group gene products in nonhuman primates. Immunogenet 1995 ; 41 : 271-81.
22. Tippett P, Lomas-Francis C, Wallace M. The Rh antigen D : partial D antigens and associated low incidence antigens. Vox Sang 1996 ; 70 : 123-31
23. Cartron JP, Rouillac C, Le Van Kim C, Mouro I, Colin Y. Tentative model for the mapping of D epitopes on the RhD polypeptide. Transf Clin Biol 1996 ; 6 : 497-503.
24. Wilson C, Mau T, Weisgraber KH, Wardell MR, Mahley RW, Agard DA Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein Structure 1994 ; 2 : 713-8.
25. Bruce D, Perry DJ, Borg JY, Carrell RW, Wardell MR. Thromboembolic disease due to thermolabile conformation changes of antithrombin Rouen-VI (187 Asn → Asp). J Clin Invest 1994 , 94 : 2265-74.
26. Jones J, Scott ML, Voak D. Monoclonal anti-D specificity and RhD structure : criteria for selection of monoclonal anti-D reagents for routine typing of patients and donors. Transf Med 1995 , 5 : 171-84.
27. Scott ML, Voak D, Jones JW, Avent ND, Liu W, Hughes-Jones NC, Sonneborn HH. A structural model for 30 RhD epitopes based on serological and DNA sequence data from partial D phenotypes. Transf Clin Biol 1996 ; 6 : 391-6.
28. Smythe JS, Avent ND, Judson PA, Parsons SF, Martin PG, Anstee DJ. Expression of RHD and RHCE gene products using retroviral transduction of K562 cells establishes the molecular basis of Rh blood group antigens. Blood 1996 ; 87 : 1968-73
29. Hermand P, Mouro I, Huet M, Bloy C, Suyama K, Golstein J, Cartron JP, Bailly P. Immunochemical characterization of Rh proteins with antibodies raised against synthetic peptides. Blood 1993 , 82 : 669-76.
30. Gr variant. Br J Haematol 1996 ; 93 : 472-4.
31. W gene complexes. Blood 1994 , 12 . 4354-60.
32. N phenotypes. Blood 1996 ; 87 : 4853-61.
33. Huang CH. Alteration of RH gene structure and expression in human dCCee and DCw- red blood cells: phenotypic homozygosity versus genolypic heterozygosity. Blood 1996 ; 88 . 2326-33.
34. Huang CH, Chen Y, Reid M, Ghosh S. Genetic recombination at the human RH locus : a family study of red cell Evans phenotype reveals a transfer of exons 2-6 from the RHD to the RHCE gene. Am J Hum Genet 1996 ; 59 : 825-33.
35. Chérif-Zahar B, Raynal V, Cartron JP. Lack of RHCE-encoded proteins in the D- phenolype may result from homologous recombination between the two RH genes. Blood 1996 ; 88 : 1518-20.
36. Matassi G, Cherif-Zahar B, Mouro I, Cartron JP. Characterization of the recombination hot spot involved in the genomic rearrangement leading to the hybrid D-CE-D gene in the DVI phenotype. Am J Hum Genet 1997 ; 60 . 808-17.
37. Kemp TJ, Poulter M, Carritt B. A recombination hot spot in the Rh genes revealed by analysis of unrelated donors with the rare D- phenotype. Am J Hum Genet 1996 ; 59 : 1066-73.
38. Tippett P. Regulator genes affecting red cell antigens. Transf Med Reviews 1990 ; 1 : 56-68.
39. Moore S, Green C. The identification of specific Rhesus polypeptide blood group ABH active glycoprotein complexes in the human red cell membrane Biochem J 1987 ; 244 : 735-41
40. Von dem Borne AEG, Bos MJE, Lomas C, Tippett P, Bloy C, Hermand P, Cartron JP, Admiraal LG, van de Graaf J, Overbeeke MAM Murine monoclonal antibodies against a unique determinant of erythrocytes related to Rh and U antigens. Br J Haematol 1990 ; 75 254-61.
41. Mallinson G, Anstee DJ, Avent ND, Ridgwell K, Tanner MJA, Daniels GL, Tippelt P, Von dem Borne AEG. Murine monoclonal antibody MB-2D10 recognizes Rh-related glycoproteins in the human red cell membrane. Transfusion 1990 ; 30 : 222-5.
42. Ridgwell K, Spurr NK, Laguda B, Maggeoch C, Avent ND, Tanner MJA. Isolation of cDNA clones for a 50 kDa glycoprotein of the erythrocyte membrane associated with Rh (Rhesus) blood-group antigen expression. Biochem J 1992 ; 287 : 223-8.
43. Eyers S, Ridgwell K, Mawby WJ, Tanner MJA. Topology and organization of the human Rh (Rhesus) blood group-related polypeptides. J Biol Chem 1994 ; 269 : 6417-23.
44. Avent ND, Liu W, Warner KM, Mawby WJ, Jones JW, Ridgwell K, Tanner MJA. Immunochemical analysis of the human erythrocyte Rh polypeptides. J Biol Chem 1996 ; 271 : 14233-9.
45. Mawby WJ, Holmes CH, Anstee DJ, Spring FA, Tanner MJA. Isolation and characterization of CD47 glycoprotein : a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3. Biochem J 1994 ; 304 : 525-30.
46. Brown E, Hooper L, Ho T, Greshom H. Integrin-associated protein : a 50 kDa plasma membrane antigens physically and functionally associated with integrins. J Cell Biol 1990 ; 111 : 2785-94.
47. Campbell IG, Freemont PS, Foulkes W, Trowsdale J. An ovarian tumor marker with homology to vaccinia virus contains an lgV-like region and multiple transmembrane domains. Cancer Res 1992 , 52 . 5416-20.
48. Lindberg FP, Lublin DM, Telen MJ, Veile RA, Miller YE, Donis-Keller H, Brown EJ. Rh-related antigen CD47 is the signal transducer integrin-associated protein. J Biol Chem 1994 , 269 : 1567-70.
49. Avent ND, Judson PA, Parsons SF, Mallinson G, Anstee DJ, Tanner MJA, Evans PR, Hodges EE, Maciver AG, Holmes C. Monoclonal antibodies that recognize different membrane proteins that are deficient in Rh-null human erythrocytes. Biochem J 1987 ; 251 : 499-505.
50. Miller YE, Daniels GL, Jones C, Palmer DK. Identification of a cell-surface antigen produced by a gene on human chromosone 3 (cenq22) and not expressed by Rh-null cells. Am J Hum Genef 1987 ; 41 : 1061-70.
51. Schwarte MA, Brown E, Fazeli B. A 50 kDa integrin-associated protein is required for integrin-regulated calcium entry in endothelial cells. J Biol J Chem 1993 , 268 : 19931-4
52. Gao AG, Lindberg FP, Finn Mary Beth, Blystone SD, Brown EJ, Frazier WA. Integrin-associated protein is a receptor for the C terminal domain of thrombospondin. J Biol Chem 1996 ; 271 : 21-4.
53. Cooper D, Lindberg FP, Gamble JR, Brown EJ, Vadas MA. Transendothelial migration of neutrophils involves integrin-associated protein (CD47). Proc Natl Acad Sci USA 1995 ; 92 : 3978-82.
54. Lindberg FP, Bullard DC, Caver TE, Gresham HD, Beaudet AL, Brown EJ. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 1996 ; 274 : 795-8.
55. Bailly P, Hermand P, Callebaut I, Sonneborn HH, Khamlichi S, Mornon JP, Cartron JP. The LW blood group glycoprotein is homologous to intercellular adhesion molecules. Proc Natl Acad Sci USA 1994 ; 91 : 5306-10.
56. Dahr W, Kordowicz M, Moulds J, Gielen W, Lebeck L, Krueger J Characterization of the Ss sialoglycoprotein and its antigens in Rh-null erythrocytes. Blut 1987 ; 54 : 13-24.
57. Cartron JP, Rahuel C. Human erythrocyte glycophorins protein and gene structure analysts. Transf Med Reviews 1992 ; 6 : 63-92.
58. Fukuda M. Molecular genetics of the glycophorin A gene cluster. Seminars Hematol 1993 , 30 : 138-51
59. b antigen to an interaction between glycophorin A and Band 3. Blood 1990 , 76 : 842-8
60. Posvol G, Clough B, Carlsson Malaria and the red cell membrane. Blood Reviews 1992 ; 6 . 183-92.
61. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH. A receptor for the malarial parasite Plasmodium vivax : the erythrocyte chemokine receptor. Science 1993 ; 261 : 1182-4.
62. Chaudhuri A, Polyakova J, Zbrzezna V, Williams K, Gulati S, Pogo AO. Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci USA 1993 ; 90 : 10793-7.
63. Neote K, Mak JY, Kolakowski LF Jr, Schall TJ. Functional and biochemical analysis of the cloned Duffy antigen : identity with the red blood cell chemokine receptor. Blood 1994 ; 84 . 44-52.
64. Hadley TJ, Liu Zh, Wasniowska K, Martin AW, Peiper SC, Hesselgesser J, Horuk R. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J Clin Invest 1994 ; 94 : 985-91.
65. Chaudhuri A, Nielsen S, Elkjaer ML, Zbrzezna V, Fang F, Pogo AO. Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of non erythroid organs. Blood 1997 ; 89 : 701-12.
66. Horuk R, Martin A, Hesselgesser J, Hadley T, Liu Zh, Wang Zx, Peiper SC. The Duffy antigen receptor for chimiokines : structural analysis and expression in brain. J Leuk Biol 1996 ; 59 : 29-38.
67. Ridgwell K, Eyers S, Mawby WJ, Anstee DJ, Tanner MJA. Studies on the glycoprotein associated with Rh (Rhesus) blood group antigen expression in the human red blood cell membrane. J Biol Chem 1994 ; 269 : 6410-6.
68. Hartel-Schenk S, Agre P. Mammalian red cell membrane Rh polypeptides are selectively palmitoylated subunits of a macromolecular complex. J Biol Chem 1992 ; 267 : 5569-84.
69. Paradis G, Bazin R, Lemieux R. Protective effect of the membrane skeleton on the immunologic reactivity of the human red cell Rho(D) antigen. J Immunol 1986 ; 137 : 240-4.
70. Peters LL, Shivdasani RA, Liu SC, Hanspal M, John KM, Gonzalez JM, Brugnara C, et al Anion exchanger 1 (Bans 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell 1996 ; 86 : 917-27.
71. Southgate CD, Chishti AH, Mitchell B, Yi SJ, Palek J. Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anemia despite a normal skeleton Nature Genet 1996 ; 14 : 227-30.
72. Allosio N, Dalla Venezia N, Rana A, Andrabi K, Texier P, Gilsanz F, Cartron JP, Delaunay J, Chishti AH. Evidence that the red blood cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C. Blood 1993 ; 82 : 1323-7.
73. Alloisio N, Morlé L, Bachir D, Guetarni D, Colonna P, Delaunay J. Red cell membrane sialoglycoprotein in homozygous and heterozygous 4.1(-) hereditary elliptocytosis. Biochim Biophys Acta 1985 ; 816 : 57-62.
74. Anstee DJ, Parsons SF, Ridgwell K, Tanner MJA, Merry AH, Thomson EE, Judson PA, et al. Two individuals with elliptocytic red cells lack three minor erythrocyte membrane sialoglycoproteins Biochem J 1984 ; 218 : 615-9.
75. Discher DE, Mohandas N, Evans EA. Molecular maps of red cell deformation : hidden elasticity and in situ connectivity. Science 1994 ; 266 : 1032-5
76. Chérif-Zahar B, Le Van Kim C, Raynal V, D'Ambrosio AM, Bailly P, Cartron JP, Colin Y. Structure and expression of the RH locus in the Rh-deficiency syndrome. Blood 1993 ; 82 : 656-62.
77. Chérif-Zahar B, Raynal V, Gone P, Mattei MG, Bailly P, Gibbs B, Colin Y, Cartron JP. Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency. Nature Genet 1996 ; 12 : 168-73.
78. Majsky A. Some cases of leukemia with modifications of the D (RhO)-receptor. Neoplasma 1967 ; 14 : 335-44.
79. Bracey AW, McGinniss MH, Levine RM, Whang-Peng J Rh mosaicism and aberrant MNSs antigen expression in a patient with chronic myelogenous leukemia. Am J Clin Pathol 1983 ; 97 : 397-401.
80. Cooper B, Tishler PV, Atkins L, Breg WR. Loss of Rh antigen associated with acquired Rh antibodies and a chromosome translocation in a patient with myeloid metaplasia. Blood 1979 ; 54 : 642-7.
81. Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997 , 89 : 1121-32.
82. Devaux PF. Static and dynamic lipid asymmetry in cell membranes. Biochemistry 1991 ; 30 : 1163-73
83. Auland ME, Roufogalis BD, Devaux PF, Zachowski A. Reconstitution of ATP-dependent aminophospholipld translocation in proteoliposomes. Proc Natl Acad Sci USA 1994 ; 91 : 10938-42.
84. Schroit AJ, Bloy C, Connor J, Cartron JP. Involvement of Rh blood group polypeptides in the maintenance of aminophospholipid asymmetry. Biochem 1990 ; 29 : 10303-6.
85. null erythrocytes. J Biol Chem 1992 ; 267 : 26050-5.
86. Smith RE, Daleke DL. Phosphatidylserine transport in Rh-null erythrocytes. Blood 1990 ; 76 . 1021-7.
87. Desneves J, Berman A, Dynon K, La Greca N, Foley M, Tilley L. Human erythrocyte band 7.2b is preferentially labeled by a photoreactive phospholipid. Biochem Biophys Res Commun 1996 ; 224 . 108-14.
88. Tang X, Halleck MS, Schlegel RA, Williamson P. A subfamily of P-type ATPases with aminophospholipid transporting activity. Science 1996 ; 272 : 1495-7.
89. Mouro I, Schlegel R, Williamson P, Halleck MS, Zachowski A, Devaux P, Cartron JP, Colin Y. Isolement d'un ADNc codant une ATPase humaine potentiellement impliquée dans la répartition asymétrique des phospholipides de la membrane des globules rouges. Hématologie 1997 ; 3 (suppl.) . 19 (abstract).
90. Bennett PR, Le Van Kim C, Colin Y, Warwick RM, Cherif-Zahar B, Fisk NM, Cartron JP Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med 1993 ; 329 : 607-10.
91. Lo YMD, Bowell PJ, Selinger M, Mackenzie IZ, Chamberlin P, Gillmer MDG, Littlewood TJ, Fleming KA, Wainscoat JS. Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers, Lancet 1993 ; 41 : 1147-8.
92. Le Van Kim C, Mouro I, Brossard Y, Chavinié J, Cartron JP, Colin Y. PCR-based determination of Rhc and RhE status of fetuses at risk of Rhc and RhE haemolytic disease Br J Haematol 1994 ; 88 : 193-5.
93. Simsek S, Faas BHW, Bleeker PMM, Overbeeke MAM, Cuijpers HTHM, van der School CE, von dem Borne AEG. Rapid RhD genotyping by polymerase chain reaction-based amplification of DNA. Blood 1995 ; 85 2975-80.
94. Aubin JT, Le Van Kim C, Mouro I, Colin Y, Bignozzi C, Brossard Y, Cartron JP. Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification Br J Haematol 1997 ; 98 : 000-000.